Efalizumab
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.
Product Specifications
CAS Number
214745-43-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Integrin
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
494444 100 µL
TRAF7 (E3 Ubiquitin-Protein Ligase TRAF7, TNF Receptor-Associated Factor 7, E3 Ubiquitin Protein Ligase)
Ask
View Details 
MBS1087617-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein ymfJ (ymfJ)
Ask
View Details MBS1087617-02 0.1 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein ymfJ (ymfJ)
Ask
View Details